Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The Phase 3 program in Mexico dropped 1.0 mg and only tested 0.25 mg and 0.5 mg
Some of the Medicaid programs that they don't cover it are excluded from the $499 price, and they'd have to pay the full price
However Lillys demonstration that a GIP/GLP-1 receptor co-agonist (tirzepatide) has superior efficacy compared to selective GLP-1 receptor agonists, has renewed interest in the first incretin. Lilly rolled out their SURPASS trials to position their agent amongst existing diabetes medications and GLP-1 agonists
If pregnancy is on your horizon, raise it at your review early rather than late, and if you become pregnant unexpectedly during treatment, stop the tablets and contact your clinician promptly rather than waiting for the next appointment
)
US$ 25.25
US$ 28.95
US$ 25.64
US$ 24.50
